Navigation Links
New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia

Six-Month Data Show Bifeprunox Maintained Stability Significantly Longer than Placebo and had a Favorable Weight and Lipid Profile Comparable with Placebo

MARIETTA, Ga. and COLLEGEVILLE, Pa., May 22, 2007 - Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, today at the 2007 annual meeting of the American Psychiatric Association. New analyses of six-month data in stabilized adult patients with schizophrenia from a double-blind, placebo-controlled study demonstrated that bifeprunox maintained stability vs. placebo and displayed a favorable weight and lipid profile comparable with placebo.

"Schizophrenia is a chronic, lifelong illness, and long-term management of the illness presents many challenges," comments Daniel Casey, M.D., Professor, Psychiatry and Neurology, Oregon Health and Science University. "Clinicians need new treatment options to help patients manage schizophrenia over the long term."

A synopsis of abstracts containing bifeprunox data presented at the meeting follows:

o In analyses of data from one Phase 3, six-month, randomized, double-blind, placebo-controlled study:

* Compared with placebo, bifeprunox significantly prolonged time to deterioration over six months.

* Bifeprunox patients experienced decreases in body weight and body mass index vs. placebo over six months.

* Bifeprunox patients showed favorable effects on total cholesterol, triglycerides, very low-density lipoprotein and low-density lipoprotein, comparable with placebo over a six-month period.

In these analyses, the most common side effects reported with bifeprunox (incidence of greater than or equal to 5 percent and twice the placebo rate) included nausea, vomiting, dizziness, anorexia, akathisia, dyski
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
3. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
4. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
5. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
6. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
7. UCB Presents Long-Term CImzia Data in Crohns Disease
8. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
11. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
Post Your Comments:
(Date:7/29/2014)... July 29, 2014 Apex Medical Corporation (Apex, TWSE: ... Area Care sectors, announces that it is appealing the judgment ... in Germany that found the headgear ... that it has initiated invalidity challenges against various ResMed patents ... counterattacking against trivial and junk patents. ResMed ...
(Date:7/29/2014)... SAN DIEGO , July 29, 2014 /PRNewswire/ ... of Nancy Thornberry to its board ... and franchise head, Diabetes and Endocrinology for Merck ... research, strategy and overall pipeline management in diabetes, ... scientist, initiated and co-led the program that resulted ...
(Date:7/29/2014)... July 29, 2014  Encision Inc. (OTCQB:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... June 30, 2014. The Company posted quarterly ... loss of $202 thousand, or $(0.02) per share. These ... a net loss of $311 thousand, or $(0.04) per ...
Breaking Medicine Technology:Apex Continues Fighting Against Patents to Free Up Competition 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... CHENGDU, China , May 7 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... and sells modernized traditional Chinese medicine,("TCM") and branded generics based in ... call to discuss its fiscal 2010 third,quarter results at 9:00 a.m. ... , , ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today announced its fiscal 2010 third quarter ... on May 6, 2010 , and is payable on June 30, 2010 , to ... , , ... , Hill-Rom is a leading ...
Cached Medicine Technology:Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 2Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 3
(Date:7/29/2014)... 29, 2014 CRN International has promoted ... Operation. , Christina Upton, an 11-year veteran at the ... Services responsible for managing the day-to-day execution of all ... the center of all activities for CRN clients, which ... the world . The department interfaces directly with clients, ...
(Date:7/29/2014)... 2014 Healthcare staffing agency Medical ... of Tomorrow Scholarship Competition winners:, , ... ,     Racheal D., Freshman, Cerritos College in ... Community College in Houston, TX , ... Solutions hosts the Nurses of Tomorrow Scholarship competition ...
(Date:7/29/2014)... July 29, 2014 1WorldSync announces ... leading healthcare suppliers will utilize the Global Data ... information network to share product information with the ... trading partners across their global supply chain. Holger ... at B. Braun: "B. Braun serves customers in ...
(Date:7/29/2014)... Burlington, VT (PRWEB) July 29, 2014 ... image management solutions, announced today the release of ... Portal, version 11.5. , Mach7’s Physician & ... physicians and patients. Patients gain access to a ... imaging files. Mach7 seamlessly consolidates complete patient care ...
(Date:7/29/2014)... Collierville, TN (PRWEB) July 29, 2014 ... to the reimbursement model of all hospitals. Studies show ... tsunami.[1] One simple, easy, low cost tool that ... organizational performance by 20 to 25%. , Their secret? ... to one anther at the end of an operational ...
Breaking Medicine News(10 mins):Health News:CRN International Names New Director to Lead Client Services Department 2Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 3Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 2Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 3Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 3
... 26 ( www.amdl.com ) China continues to show ... Inc. (NYSE Alternext US: ADL) Chairman and CEO Mr. ... of an internal economic forecast research report indicating China ... the world, eclipsing every other international market.Mr. MacLellan has ...
... NEW YORK, Jan. 26 The National Center on ... announced today that Bruce E. Mosler has been ... ) , Mosler, president and CEO of Cushman ... estate services firm and serves on its board of ...
... hard work and dedication to the highest quality of care ... ... 26, 2009 -- Sierra Tucson, a premier treatment center dedicated ... disorders, today announced the achievement of accreditation as a "Hospital" ...
... LOUIS, Jan. 26 KV Pharmaceutical,(NYSE: KVa/KVb) has voluntarily suspended ... certain products that it distributes but does,not manufacture. The ... Additionally, the company will conduct a voluntary recall of ... recall are currently under discussion,with the U.S. Food and Drug ...
... Mass., Jan. 26 Instrumentation Laboratory (IL) today ... its contract to offer IL,s critical care portfolio ... history between the two companies, whose original contract ... of critical care analyzers, reagents, consumables and service, ...
... Medimetriks Pharmaceuticals announced today that the Company has ... PRGO ), a leading manufacturer in the ... Distributor of generic versions of Medimetriks, branded products in ... receive a percentage of Perrigo,s Net Sales on the ...
Cached Medicine News:Health News:AMDL, Inc. Chairman & CEO Announces Expert Opinion on China's Economic Forecast 2Health News:Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board 2Health News:Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board 3Health News:Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission 2Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 2Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 3Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 4Health News:KV Pharmaceutical Suspends Product Manufacturing, Shipping 5Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 2Health News:Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio 3Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 2Health News:Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals 3
... Used for catheter or instrument ... features a fabrication process that eliminates ... and introducer dilator, facilitating introduction through ... reinforcement sleeve prevents movement between introducer ...
... Used for temporary internal ... junction to the bladder. ... packages. Intended for one-time ... is advised; C-Flex® and ...
... or instrument introduction. The dual knobs ... away and removed. The maximum diameter ... be introduced should be measured to ... Supplied sterile in peel-open packages. Intended ...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: